(Total Views: 461)
Posted On: 08/17/2021 9:21:10 PM
Post# of 154140
I am not able to read the article. "You have reached your free article limit" -- I read ONE article there this month. However someone sent me the bullet points at the top. The loaded and negative language made it clear that it would be a bash, whether soft or hard, who cares.
Do you sense a little sarcasm here?
Do you sense a little sarcasm here?
Quote:
CytoDyn has a single asset - leronlimab - which it is running through trials in nearly every major disease known to man.
The stock has seen huge movement after the company started with covid-19.
If the company manages to file its HIV BLA, the stock could shoot up.
(3)
(0)
